Fig. 6. UCP2 and UCP3 mRNA expression is regulated by ghrelin.
Prolong exposure to Ghrelin increase both UCP2 and UCP3 mRNA expression levels (A–B) in a dose dependent manner (C–D). Anti-suavagine 30, a specific CRF-R2 inhibitor, blocked this effect of ghrelin on both, UCP2 and UCP3 mRNA levels (E-F). The examples shown are representative of at least three experiments. * p<0.05 vs. control.
